Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Business News Icpt Stock Pops After Intercept Staves Off Amneal S Ocaliva Knockoff Investor S Business Daily Investor S Business Daily is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Intercept's (ICPT) Stock Rises After Layoff Announcement - Yahoo Finance

Shares of Intercept Pharmaceuticals, Inc. ICPT were up 3.5% on Wednesday, after it announced that it will lay off 25% of its workforce, or about 170 employees. The company made the announcement ... Read More
Semtech's stock pops after sales hike shows business has 'progressed from stable to growing' - Morningstar

Semtech Corp.'s stock initially soared 17% before cooling a bit in extended trading Thursday after the company rang up better-than-expected sales and strong sales guidance for its current quarter. Read More
Intercept (ICPT) Stock Gains 13% in 3 Months: Here's Why - Yahoo Finance

Shares of Intercept Pharmaceuticals, Inc. ICPT have jumped 13% in the last three months against the industry’s decline of 9.7% on a string of positive updates in the time frame. In July 2022 ... Read More
ICPT stock gains after patent settlement with Amneal (NASDAQ:ICPT)

Intercept Pharma (ICPT) shares gained Wednesday after a deal with generic drugmaker Amneal Pharma (AMRX) to settle a patent dispute over liver drug Ocaliva. Read the full story here. Read More
ICPT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Intercept Pharmaceuticals, Inc. Is Fair to Shareholders - Business Wire

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) to Alfasigma S.p.A. for $19.00 per ... Read More
Intercept to reduce work force by one third as it aims for profitability

It continues to project sales of $310 million to $340 million for its Ocaliva product. It plans to reduce expenses by about $140 million. Intercept stock is down 0.5% in premarket trades on Friday. Read More
Heres Why Intercept (ICPT) Stock is Up 28.7% in 3 Months - Yahoo News UK

Shares of Intercept Pharmaceuticals, Inc. ICPT surged 28.7% in the past 3 months compared with the industry’s decline of 10.3%. The main catalyst for this surge was the FDA’s acceptance of Intercept’s ... Read More
Intercept's (ICPT) Stock Rises After Layoff Announcement

Shares of Intercept Pharmaceuticals, Inc. ICPT were up 3.5% on Wednesday, after it announced that it will lay off 25% of its workforce, or about 170 employees. Read More
Why Is Intercept Pharmaceuticals (ICPT) Stock Down 20% Today?

Today is a big day for Intercept Pharmaceuticals (NASDAQ:ICPT). The company just announced the clinical-trial results of Intercept’s treatment for NASH cirrhosis. Unfortunately, those results ... Read More
Intercept (ICPT) Stock Gains 13% in 3 Months: Here's Why

Shares of Intercept Pharmaceuticals, Inc.ICPT have jumped 13% in the last three months against the industry’s decline of 9.7% on a string of positive updates in the time frame.. In July 2022 ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus